newsfilter
← Latest News
GlobeNewswire·

Oncocyte's VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

IRVINE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ:OCX), a molecular diagnostics technology company, announced the recent publication of a case series of two kidney transplant patients who were